These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 29657904)

  • 1. Immunotherapy for Breast Cancer: Current and Future Strategies.
    Williams AD; Payne KK; Posey AD; Hill C; Conejo-Garcia J; June CH; Tchou J
    Curr Surg Rep; 2017 Dec; 5():. PubMed ID: 29657904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combining Oncolytic Viruses With Cancer Immunotherapy: Establishing a New Generation of Cancer Treatment.
    Shi T; Song X; Wang Y; Liu F; Wei J
    Front Immunol; 2020; 11():683. PubMed ID: 32411132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current Advances in Immunotherapy for Glioblastoma Multiforme and Future Prospects.
    Chowdhury S; Bappy MH; Clocchiatti-Tuozzo S; Cheeti S; Chowdhury S; Patel V
    Cureus; 2021 Dec; 13(12):e20604. PubMed ID: 35103180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of Immunotherapy in Targeting the Bone Marrow Microenvironment in Multiple Myeloma: An Evolving Therapeutic Strategy.
    Chung C
    Pharmacotherapy; 2017 Jan; 37(1):129-143. PubMed ID: 27870103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostate Cancer Immunotherapy-Finally in From the Cold?
    Runcie KD; Dallos MC
    Curr Oncol Rep; 2021 Jun; 23(8):88. PubMed ID: 34125308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunotherapy in breast cancer: An overview of modern checkpoint blockade strategies and vaccines.
    Sanchez K; Page D; McArthur HL
    Curr Probl Cancer; 2016; 40(2-4):151-162. PubMed ID: 27855963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emerging immunotherapeutic strategies for the treatment of breast cancer.
    Huppert LA; Mariotti V; Chien AJ; Soliman HH
    Breast Cancer Res Treat; 2022 Jan; 191(2):243-255. PubMed ID: 34716870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunotherapy for pancreatic cancer: A long and hopeful journey.
    Xu JW; Wang L; Cheng YG; Zhang GY; Hu SY; Zhou B; Zhan HX
    Cancer Lett; 2018 Jul; 425():143-151. PubMed ID: 29605510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic Potential of Lymphoid Infiltrates in Breast Cancer.
    Chen XY; Tan PH
    Curr Med Chem; 2021; 28(25):5152-5178. PubMed ID: 33938409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Immune Landscape of Breast Cancer: Strategies for Overcoming Immunotherapy Resistance.
    Retecki K; Seweryn M; Graczyk-Jarzynka A; Bajor M
    Cancers (Basel); 2021 Nov; 13(23):. PubMed ID: 34885122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent Advances and Challenges in Cancer Immunotherapy.
    Peterson C; Denlinger N; Yang Y
    Cancers (Basel); 2022 Aug; 14(16):. PubMed ID: 36010965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunotherapy for the treatment of breast cancer: checkpoint blockade, cancer vaccines, and future directions in combination immunotherapy.
    McArthur HL; Page DB
    Clin Adv Hematol Oncol; 2016 Nov; 14(11):922-933. PubMed ID: 27930644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Engineering Newcastle Disease Virus as an Oncolytic Vector for Intratumoral Delivery of Immune Checkpoint Inhibitors and Immunocytokines.
    Vijayakumar G; McCroskery S; Palese P
    J Virol; 2020 Jan; 94(3):. PubMed ID: 31694938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current Immunotherapeutic Approaches for Malignant Gliomas.
    Han MH; Kim CH
    Brain Tumor Res Treat; 2022 Jan; 10(1):1-11. PubMed ID: 35118842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Role of Immunological Synapse in Predicting the Efficacy of Chimeric Antigen Receptor (CAR) Immunotherapy.
    Liu D; Badeti S; Dotti G; Jiang JG; Wang H; Dermody J; Soteropoulos P; Streck D; Birge RB; Liu C
    Cell Commun Signal; 2020 Aug; 18(1):134. PubMed ID: 32843053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer immunotherapy: the beginning of the end of cancer?
    Farkona S; Diamandis EP; Blasutig IM
    BMC Med; 2016 May; 14():73. PubMed ID: 27151159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Innovative and Promising Strategies to Enhance Effectiveness of Immunotherapy for CNS Tumors: Where Are We?
    Quintarelli C; Camera A; Ciccone R; Alessi I; Del Bufalo F; Carai A; Del Baldo G; Mastronuzzi A; De Angelis B
    Front Immunol; 2021; 12():634031. PubMed ID: 34163465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advances in Anti-Cancer Immunotherapy: Car-T Cell, Checkpoint Inhibitors, Dendritic Cell Vaccines, and Oncolytic Viruses, and Emerging Cellular and Molecular Targets.
    Alard E; Butnariu AB; Grillo M; Kirkham C; Zinovkin DA; Newnham L; Macciochi J; Pranjol MZI
    Cancers (Basel); 2020 Jul; 12(7):. PubMed ID: 32645977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunotherapy for triple-negative breast cancer: Existing challenges and exciting prospects.
    Jia H; Truica CI; Wang B; Wang Y; Ren X; Harvey HA; Song J; Yang JM
    Drug Resist Updat; 2017 May; 32():1-15. PubMed ID: 29145974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer Immunotherapy: Diverse Approaches and Obstacles.
    Sanatkar SA; Heidari A; Rezaei N
    Curr Pharm Des; 2022; 28(29):2387-2403. PubMed ID: 35909273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.